Blinatumomab for B-cell ALL Relapse, IVIG for MIS-C, Review of Irritable Bowel Syndrome, and more

Editor's Summary by Mary McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the March 2, 2021 issue

Source: JAMA: This Week's Audio Commentary - March 2, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts